The week so far: stocks stay in positive territory, Mesoblast surges
We take a look at some of the key market moves from Monday to Thursday.
ASX 200: a tale of two halves
Australia 200 shares have slipped from mid-week highs but are still in positive territory overall.
The benchmark ASX 200 index finished Thursday’s session at 5,364.20 points, up 44.4 points, or 0.8% for the week.
So far, the week has been a tale of two halves. On Tuesday, the index closed at 5,407.10 points, up 161.20 points, or 3.1% for the first two sessions of the week. The result was driven predominantly by banks and energy shares, with materials only slightly up and healthcare down.
By Thursday’s close, the roles had changed. The ASX 200 Financials index slipped into negative territory, down 0.5% for the week.
Healthcare on the other hand turned positive, up 0.5%, while energy shares were off their Tuesday highs, but still up 3.3%. Materials also helped out on the mining heavy ASX 200, rising from modest gains on Tuesday to be up 2.8% with one day left in the week.
Healthcare and Energy stocks in focus
As the index started to come off its midweek highs the news turned towards healthcare companies, which are thought of by many as counter-cyclical and useful during an economic downturn.
Blood plasma giant CSL Ltd (CSL) finished Thursday’s session at $307.93, down 1.9% for the week. The company conducted a US$750 million debt raising ‘for general corporate purposes.’
Elsewhere in the sector things were looking positive. Bionic-ear maker Cochlear Ltd (COH) rose 2.9% to $184.50, while Sonic Healthcare Ltd (SHL) jumped 5.6% for the week so far to last trade at $25.86.
But all eyes were on regenerative medicine company Mesoblast (MSB), which surged by 12.5% on Wednesday after news broke that it had started phase 2/3 of a trial treating 300 patients in the US with severe Covid-19 symptoms. The company’s shares are up 9.6% for the week to $3.54.
While Mesoblast isn’t in the ASX 200 for the moment, some have speculated that it could soon be. The company’s share price has shot up from $1.11 on 23 March and its market capitalisation of $1.8 billion is higher than a number of companies currently included in the ASX 200 index.
Energy shares also came off a shade, though still remained elevated, as oil prices eased from a strong rally.
Woodside Petroleum Ltd (WPL) shares were still up 6.4% for the week so far – from Monday to Thursday – to $21.65, rival Santos Ltd (STO) leapt 9.7% to $4.76, Oil Search Ltd (OSH) jumped 10% per cent to $2.87. Meanwhile, Origin Energy Ltd surged 14.3% $5.53 and AGL Energy Ltd lost 4.2% to end at $16.39.
Petrol company Caltex Australia Ltd (CTX) said the crude oil market has weakened significantly. Tanker storage had increased, which pushed up freight rates. Adding to that, demand for jet fuel and petrol have fallen hard.
Even so, Caltex shares were still up 8.5% for the week to $24.34.
In economic news, Australia booked a record trade surplus of $10.6 billion in March, while retail spending rose by a record 8.5 per cent thanks to the panic buying that ensued in the wake of Covid-19.
How to trade indices: long and short
What do you make of the current situation: do you see bullish or bearish opportunities? Whatever your opinion, you can trade indices, currencies and equities – both LONG or SHORT – with IG’s world-class trading platform now.
For example, to buy (long) or sell (short) the ASX 200 index using CFDs, follow these easy steps:
This information has been prepared by IG, a trading name of IG Markets Limited. In addition to the disclaimer below, the material on this page does not contain a record of our trading prices, or an offer of, or solicitation for, a transaction in any financial instrument. IG accepts no responsibility for any use that may be made of these comments and for any consequences that result. No representation or warranty is given as to the accuracy or completeness of this information. Consequently any person acting on it does so entirely at their own risk. Any research provided does not have regard to the specific investment objectives, financial situation and needs of any specific person who may receive it. It has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such is considered to be a marketing communication. Although we are not specifically constrained from dealing ahead of our recommendations we do not seek to take advantage of them before they are provided to our clients. See full non-independent research disclaimer and quarterly summary.
Seize a share opportunity today
Go long or short on thousands of international stocks.
- Increase your market exposure with leverage
- Get spreads from just 0.1% on major global shares
- Trade CFDs straight into order books with direct market access
Live prices on most popular markets